This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
New Immuno-Oncology Solutions (NIOS): Aligning Stakeholders in the Biotech Industry
Vroom, Govert; Maribel Berges; Sastre Boquet, IsaacCase SM-1701-EEntrepreneurship, Innovation and Change, StrategyThis case focuses on a small biotech company (NIOS), located in Barcelona, Spain, that is developing a new immune-oncology product for treating pancreatic cancer. The drug that the company is developing has recently finished Phase I of clinical trials successfully and is now preparing for Phase II and III. At this point, the CEO is approached by her former PhD director, a university professor, who asks if the company is interested in licensing a ...Starting at €8.20
-
Note on Scenario Planning in High-Uncertainty Environments: The Disruption Matrix
Costa, Carlos; Nueno, José LuisTechnical Note MN-405-EDecision Analysis, Innovation and Change, StrategyThe coronavirus pandemic is an unexpected external event with a profound impact on demand in all sectors that is highly conditioned by decisions that correspond to external stakeholders. After overcoming their initial shock, within this context companies have to think about their future in two or three years; however, it is very difficult for the management team to plan and define a clear strategy when it remains unknown when and how they will be...Starting at €8.20
-
New Immuno-Oncology Solutions (NIOS) - Teaching Note: Aligning stakeholders in the biotech industry
Vroom, Govert; Maribel Berges; Sastre Boquet, IsaacTeaching Note SMT-136-EEntrepreneurship, Innovation and Change, StrategyThis case focuses on a small biotech company (NIOS), located in Barcelona, Spain, that is developing a new immune-oncology product for treating pancreatic cancer. The drug that the company is developing has recently finished Phase I of clinical trials successfully and is now preparing for Phase II and III. At this point, the CEO is approached by her former PhD director, a university professor, who asks if the company is interested in licensing a ...Starting at €0.00
-
Nota sobre planificación por escenarios en entornos de alta incertidumbre: matriz de disrupción
Costa, Carlos; Nueno, José LuisTechnical Note MN-405Decision Analysis, Innovation and Change, StrategyLa pandemia de la COVID-19 es un suceso externo inesperado con un profundo impacto en la demanda y en la competencia de cada sector, y que se encuentra muy condicionado por decisiones que corresponden a stakeholders externos. En este entorno y tras superar el shock inicial, las empresas tienen que pensar en el futuro dentro de dos o tres años, y resulta muy difícil, para el equipo directivo, planificar y definir una estrategia determinada, cuand...Starting at €8.20